Last updated: 11/07/2018 19:16:09
A multicentre randomised, double-blind, double-dummy, parallel group six-month comparison of the salmeterol/fluticasone propionate combination product (50/250mcg strength) BID via one DISKUS/ACCUHALER inhaler with salmeterol 50mcg BID via one DISKUS/ACCUHALER inhaler and fluticasone propionate 2 ...
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A multicentre randomised, double-blind, double-dummy, parallel group six-month comparison of the salmeterol/fluticasone propionate combination product (50/250mcg strength) BID via one DISKUS/ACCUHALER inhaler with salmeterol 50mcg BID via one DISKUS/ACCUHALER inhaler and fluticasone propionate 2 ...
Trial description: A multicentre randomised, double-blind, double-dummy, parallel group six-month comparison of the salmeterol/fluticasone propionate combination product (50/250mcg strength) BID via one DISKUS/ACCUHALER inhaler with salmeterol 50mcg BID via one DISKUS/ACCUHALER inhaler and fluticasone propionate 2 ...
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Abstract: Asthma control with salmeterol and fluticasone propionate (50/20 micro gram) given twice daily in a single combination diskus (accuhaler) inhaler compared to salmeterol 50 micro gram and fluticasone propionate 205 micro gram given twice daily via two sepa. Ringdal, N, Chapman, K R, Backer, V, Palmqvist, M, Saarelainen, S, and Briggs, M 8th Annual Congress of the European Respiratory Society 9/19/1998 Geneva ,Switzerland
Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M. Salmeterol and fluticasone propionate (50/250 mcg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. Can Respir J 1999; 6 (1): 45-51
Pieters W, Ringdal N, Aubier M, Chapman KR, Huskisson SC. A new inhaler combination containing salmeterol and FP is well-tolerated in long-term use. Eur Respir J 1998; 12 (29): 20s
Ringdal N, Chapman KR, Backer V, Palmqvist M, Saarelainen S, Briggs M. Asthma control with salmeterol and fluticasone propionate (50/250 mcg) given twice daily in a single combination Diskus (Accuhaler) inhaler compared to salmeterol 50 mcg and fluticasone propionate 250 mcg given twice daily via two separate Diskus inhalers. Eur Respir J 1998; 12 (Suppl 28): 36s
Medical condition
Asthma
Product
fluticasone propionate/salmeterol
Collaborators
Not applicable
Study date(s)
October 1996 to June 1997
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1997-16-06
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website